Dabigatran
Concept
Vocabulary Service
Overview
subject area of
-
2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Academic Article
-
A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery Academic Article
-
A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN) Academic Article
-
A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system Academic Article
-
A logical approach to surgical thromboprophylaxis Academic Article
-
Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine—A Multicenter Trial Academic Article
-
Activated prothrombin complex concentrate for dabigatran-associated bleeding Academic Article
-
Acute management of bleeding in patients on novel oral anticoagulants Academic Article
-
Additional Events in the RE-LY Trial Academic Article
-
Adherence to anticoagulant treatment with dabigatran in a real‐world setting Academic Article
-
Advances in treatment and management Academic Article
-
Advantages and limitations of the new anticoagulants Academic Article
-
After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy Academic Article
-
An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150 mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery Academic Article
-
Analysis of Upper Gastrointestinal Adverse Events Among Patients Given Dabigatran in the RE-LY Trial Academic Article
-
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation Academic Article
-
Another Dimension of Safety in the Prescription of Anticoagulants for Nonvalvular Atrial Fibrillation Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Academic Article
-
Antithrombotic Therapy for Atrial Fibrillation Academic Article
-
Approach to the new oral anticoagulants in family practice: part 1: comparing the options. Academic Article
-
Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions. Academic Article
-
Assessing the impact of dabigatran and warfarin on health-related quality of life: Results from an RE-LY sub-study Academic Article
-
Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation Academic Article
-
Barriers and facilitators to optimal oral anticoagulant management: a scoping review Academic Article
-
Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time Academic Article
-
Beyond Unfractionated Heparin and Warfarin Academic Article
-
Bleeding Complications and Management on anticoagulant therapy Academic Article
-
Bleeding and antidotes in new oral anticoagulants Academic Article
-
Bleeding events with dabigatran or warfarin in patients with venous thromboembolism Academic Article
-
Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study Academic Article
-
Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience Academic Article
-
Bleeding with direct oral anticoagulants vs warfarin: clinical experience Academic Article
-
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter Academic Article
-
Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial) Academic Article
-
Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial Academic Article
-
Causes of Death and Influencing Factors in Patients With Atrial Fibrillation Academic Article
-
Changes in Renal Function in Patients With Atrial Fibrillation Academic Article
-
Clinical Experience With the New Oral Anticoagulants for Treatment of Venous Thromboembolism Academic Article
-
Clinical implications of reversal agents for direct oral anticoagulants Academic Article
-
Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications Academic Article
-
Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure Academic Article
-
Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development Academic Article
-
Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study Academic Article
-
Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm? Academic Article
-
Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial) Academic Article
-
Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Academic Article
-
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial Academic Article
-
Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial Academic Article
-
Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations Academic Article
-
Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism Academic Article
-
Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation Academic Article
-
Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial Academic Article
-
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2) Academic Article
-
Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist Academic Article
-
Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation Academic Article
-
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective Academic Article
-
D-dimer and factor VIIa in atrial fibrillation – prognostic values for cardiovascular events and effects of anticoagulation therapy Academic Article
-
DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature Academic Article
-
Dabigatran Etexilate Academic Article
-
Dabigatran Etexilate: Future Directions in Anticoagulant Treatment Academic Article
-
Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery Academic Article
-
Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment Academic Article
-
Dabigatran Reversal with Idarucizumab Academic Article
-
Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke Academic Article
-
Dabigatran Versus Warfarin Academic Article
-
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation Academic Article
-
Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function Academic Article
-
Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation Academic Article
-
Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient management Academic Article
-
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction? Academic Article
-
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial Academic Article
-
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE‐LY trial Academic Article
-
Dabigatran efficacy‐safety assessment for stroke prevention in patients with atrial fibrillation Academic Article
-
Dabigatran etexilate and reduction in serum apolipoprotein B Academic Article
-
Dabigatran etexilate for prevention of venous thromboembolism Academic Article
-
Dabigatran following acute transient ischemic attack and minor stroke II (DATAS II) Academic Article
-
Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial Academic Article
-
Dabigatran in clinical practice: Contemporary overview of the evidence Academic Article
-
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial Academic Article
-
Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve‐Induced Thrombin Generation Academic Article
-
Dabigatran monitoring made simple? Academic Article
-
Dabigatran reversal by idarucizumab in the setting of intracranial hemorrhage: A systematic review of the literature Academic Article
-
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II Academic Article
-
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II. Academic Article
-
Dabigatran versus Warfarin for Venous Thromboembolism Academic Article
-
Dabigatran versus Warfarin in Patients with Atrial Fibrillation Academic Article
-
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves Academic Article
-
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism Academic Article
-
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada Academic Article
-
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study Academic Article
-
Dabigatran-Induced Acute Hepatitis Academic Article
-
Dabigatran-related coagulopathy: when can we assume the effect has “worn off”? Academic Article
-
Dabigatran: ready for prime time? Academic Article
-
Derivation and validation of predictors of oral anticoagulant-related adverse events in seniors transitioning from hospital to home Academic Article
-
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran Academic Article
-
Design of a Randomized Placebo-Controlled Trial to Assess Dabigatran and Omeprazole in Patients with Myocardial Injury after Noncardiac Surgery (MANAGE) Academic Article
-
Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding Academic Article
-
Direct Oral Anticoagulants and Myocardial Infarction Academic Article
-
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies Academic Article
-
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials Academic Article
-
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Academic Article
-
Direct oral anticoagulants: evidence and unresolved issues Academic Article
-
Early Dabigatran Treatment After Transient Ischemic Attack and Minor Ischemic Stroke Does Not Result in Hemorrhagic Transformation Academic Article
-
Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure Academic Article
-
Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events Academic Article
-
Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi‐database cohort study with meta‐analysis Academic Article
-
Effects of dabigatran according to age in atrial fibrillation Academic Article
-
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants Academic Article
-
Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation Academic Article
-
Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation Academic Article
-
Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS<sub>2</sub> Score Academic Article
-
Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial - Academic Article
-
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Academic Article
-
Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time—A RE-LY trial analysis Academic Article
-
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™ Academic Article
-
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation Academic Article
-
Enhanced TRAP-induced platelet aggregation with dabigatran — Clinical perspective Academic Article
-
Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty Academic Article
-
Establishing Therapeutic Equivalence of Complex Pharmaceuticals: The Case of Dabigatran Academic Article
-
Evolving use of new oral anticoagulants for treatment of venous thromboembolism Academic Article
-
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism Academic Article
-
Factor Xa and thrombin as targets for new oral anticoagulants Academic Article
-
Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies Academic Article
-
Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding Academic Article
-
Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study Academic Article
-
Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review Academic Article
-
Home-monitoring of oral anticoagulation vs. dabigatran Academic Article
-
How I treat target-specific oral anticoagulant–associated bleeding Academic Article
-
How can we reverse bleeding in patients on direct oral anticoagulants? Academic Article
-
Idarucizumab Academic Article
-
Idarucizumab for Dabigatran Reversal Academic Article
-
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis Academic Article
-
Idarucizumab for Dabigatran-Related Gastrointestinal Bleeds Academic Article
-
Idarucizumab for dabigatran overdose Academic Article
-
In-vitro assessment of the effect of dabigatran on thrombosis of adult and neonatal plasma Academic Article
-
Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation Academic Article
-
Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation Academic Article
-
Intensity and Quality of Warfarin Anticoagulation in Chinese Patients Academic Article
-
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation Academic Article
-
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants Academic Article
-
Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran Academic Article
-
Is there a role for the novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials Academic Article
-
Is there really misuse and abuse of dabigatran? Academic Article
-
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants Academic Article
-
Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation Academic Article
-
Laboratory measurement of the direct oral anticoagulants Academic Article
-
Letter to the Editor Academic Article
-
Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran Academic Article
-
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation Academic Article
-
Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation Academic Article
-
Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin Academic Article
-
Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor Academic Article
-
Management of Anticoagulation Around Pacemaker and Defibrillator Surgery Academic Article
-
Management of bleeding complications in patients with cancer on DOACs Academic Article
-
Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting Academic Article
-
Measurement of Dabigatran Drug Levels to Manage Patients Taking Interacting Drugs: A Case Report Academic Article
-
Measuring Dabigatran Levels: What Tests Are Available and What Still Needs to Be Done? Academic Article
-
Monitoring and reversal of direct oral anticoagulants Academic Article
-
Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Academic Article
-
NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank Academic Article
-
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™ Academic Article
-
New Anticoagulants for Atrial Fibrillation Academic Article
-
New Anticoagulants for Treatment of Venous Thromboembolism Academic Article
-
New Anticoagulants for the Prevention of Thromboembolism Academic Article
-
New anticoagulants Conference Paper
-
New anticoagulants in atrial fibrillation management Conference Paper
-
New aspects on treatment modalities for thromboembolic episodes Academic Article
-
New oral anticoagulant agents – general features and outcomes in subsets of patients Academic Article
-
New oral anticoagulants and oculoplastic surgery Academic Article
-
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions Academic Article
-
New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty Academic Article
-
New oral anticoagulants in elderly patients Academic Article
-
New oral anticoagulants: not quite there yet Academic Article
-
New oral anticoagulants: which one should my patient use? Academic Article
-
Newly Identified Events in the RE-LY Trial Academic Article
-
News at XI: moving beyond factor Xa inhibitors Academic Article
-
Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study Academic Article
-
Novel Oral Anticoagulants: A Focused Review for Stroke Physicians Academic Article
-
Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism Academic Article
-
Novel oral anticoagulants in gastroenterology practice Academic Article
-
Novel oral anticoagulants in secondary prevention of stroke Academic Article
-
Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits Academic Article
-
Optimizing the safety of treatment for venous thromboembolism in the era of the direct oral anticoagulants Academic Article
-
Oral Anticoagulant Therapy Academic Article
-
Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease Academic Article
-
Overview of the New Oral Anticoagulants Academic Article
-
Patient outcomes using the European label for dabigatran Academic Article
-
Perioperative Management of Dabigatran Academic Article
-
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure Academic Article
-
Perioperative management of patients who are receiving a novel oral anticoagulant Academic Article
-
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin Academic Article
-
Periprocedural Management and Approach to Bleeding in Patients Taking Dabigatran Academic Article
-
Periprocedural Management of Oral Anticoagulation Academic Article
-
Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy Academic Article
-
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy Academic Article
-
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation Academic Article
-
Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran Academic Article
-
Pharmacologic Properties of the New Oral Anticoagulants: A Clinician-oriented Review with a Focus on Perioperative Management Academic Article
-
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial Academic Article
-
Post‐thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long‐term cross‐sectional follow‐up of RE‐COVER study patients Academic Article
-
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation Academic Article
-
Potential of new anticoagulants in patients with cancer Academic Article
-
Practical aspects of new oral anticoagulant use in atrial fibrillation Academic Article
-
Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban Academic Article
-
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation Academic Article
-
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Academic Article
-
Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study Academic Article
-
Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure Academic Article
-
Preventing Alzheimer’s Disease Academic Article
-
Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran Academic Article
-
Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate Academic Article
-
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate Academic Article
-
Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran Academic Article
-
Real-world variability in dabigatran levels in patients with atrial fibrillation: reply Academic Article
-
Real‐world variability in dabigatran levels in patients with atrial fibrillation Academic Article
-
Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial Academic Article
-
Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding Academic Article
-
Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation Academic Article
-
Reversal agents for current and forthcoming direct oral anticoagulants Academic Article
-
Reversal of Direct Oral Anticoagulants: Current Status and Future Directions Academic Article
-
Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study Academic Article
-
Reversal of direct oral anticoagulants: a practical approach Academic Article
-
Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit) Academic Article
-
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation Academic Article
-
Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants Academic Article
-
Risk of intracranial hemorrhage between different direct oral anticoagulants in older patients seen in the emergency department with a head injury: A population-based cohort study Academic Article
-
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial Academic Article
-
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation Academic Article
-
Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography Academic Article
-
Rivaroxaban for the prevention and treatment of venous thromboembolism Academic Article
-
Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis Academic Article
-
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment Academic Article
-
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial Academic Article
-
Strategies for the prevention and treatment of bleeding in patients treated with dabigatran: an update Academic Article
-
Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial Academic Article
-
Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease Academic Article
-
Stroke prevention in atrial fibrillation: Closing the gap Academic Article
-
Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation Academic Article
-
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2 Academic Article
-
The Cost Implications of Dabigatran in Patients with Myocardial Injury After Non-Cardiac Surgery Academic Article
-
The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients Academic Article
-
The King is Dead (Warfarin): Direct Thrombin and Factor Xa Inhibitors: The Next Diadochian War? Academic Article
-
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study Academic Article
-
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations Academic Article
-
The Oral Thrombin Inhibitor Dabigatran: Strengths and Weaknesses Academic Article
-
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale Academic Article
-
The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect Academic Article
-
The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants Academic Article
-
The top 4 advances in antithrombotic care in the last year Academic Article
-
Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding Academic Article
-
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis Academic Article
-
Treatment of acute pulmonary embolism with dabigatran versus warfarin Academic Article
-
Treatment of venous thromboembolism with dabigatran Academic Article
-
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer Academic Article
-
Trends in Prescribing Oral Anticoagulants in Canada, 2008–2014 Academic Article
-
Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review Academic Article
-
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial Academic Article
-
Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation. Academic Article
-
Venous thromboembolism management: where do novel anticoagulants fit? Academic Article
-
What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review Academic Article
-
γT‐S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo Academic Article
-
‘Real world’ use of non-vitamin K antagonist oral anticoagulants (NOACs): Lessons from the Dresden NOAC Registry Academic Article